1.
Shaneyfelt TM, Centor RM: Reassessment of clinical practice guidelines: go gently into that good night. JAMA 2009;301:868-869.
2.
Institute of Medicine: Clinical Practice Guidelines We Can Trust. Washington, Institute of Medicine, 2011.
3.
Cosgrove L, Bursztajn HJ, Erlich DR, Wheeler EE, Shaughnessy AF: Conflicts of interest and the quality of recommendations in clinical guidelines. J Eval Clin Pract 2013;19:674-681.
4.
Fournier J, DeRubeis R, Hollon S, Dimidijan S, Amsterdam J, Shelton R, Fawcett J: Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010;303:47-53.
5.
Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E: Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015;351:h4320.
6.
Baumeister H: Inappropriate prescriptions of antidepressant drugs in patients with subthreshold to mild depression: time for the evidence to become practice. J Affect Disord 2012;139:240-243.
7.
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA: The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 2016;85:270-288.
8.
International Committee of Medical Journal Editors: Conflicts of interest. International Committee of Medical Journal Editors, 2016 (accessed May 8, 2016). http://www.icmje.org/conflicts-of-interest/.
9.
National Collaborating Centre for Mental Health. Depression: The NICE Guideline on the Treatment and Management of Depression in Adults: updated edition. London, The British Psychological Society and The Royal College of Psychiatrists, 2010 (accessed May 8, 2016). http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0016605/pdf/PubMedHealth_PMH0016605.pdf.
10.
Fleck MP, Berlim MT, Lafer B, Sougey EB, Porto JAD, Brasil MA, Juruena MF: Revisão das diretrizes da Associação Médica Brasileira para o tratamento da depressão (Versão integral). Rev Bras Psiquiatr 2009;31(suppl 1):S7-S17.
11.
American Psychiatric Association: Practice Guideline for the Treatment of Patients with Major Depressive Disorder, ed 3. Washington, American Psychiatric Publishing, 2010 (accessed May 8, 2016). https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf.
12.
Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV: Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 2009;117:S26-S43.
13.
Eccles MP, Grimshaw JM, Shekelle P, Schünemann HJ, Woolf S: Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest. Implement Sci 2012;7:1-8.
14.
The Management of MDD Working Group: VA/DoD Clinical Practice Guideline for Management of Major Depressive Disorder (MDD). Washington, Department of Veteran Affairs and Department of Defense, 2009 (accessed May 8, 2016). http://www.healthquality.va.gov/mdd/mdd_full09_c.pdf.
15.
Map of Medicine: Depression - Mild to Moderate. London, Map of Medicine, 2012 (accessed May 8, 2016). http://eng.mapofmedicine.com/evidence/map/depression_in_adults2.html.
16.
University of Michigan Health Services: Depression. Ann Arbor, Regents of the University of Michigan, 2011.
17.
Mitchell J, Trangle M, Degnan B, Gabert T, Haight B, Kessler D, Mack N, Mallen E, Novak H, Rossmiller D, Setterlund L: Adult Depression in Primary Care. Bloomington, Institute for Clinical Systems Improvement, 2013.
18.
Michigan Quality Improvement Consortium: Primary Care Diagnosis and Management of Adults with Depression. Southfielld, Michigan Quality Improvement Consortium, 2016 (accessed May 8, 2016). http://www.mqic.org/pdf/mqic_primary_care_diagnosis_and_management_of_adults_with_depression_cpg.pdf.
19.
Ministry of Health, Singapore: Depression. Singapore, Ministry of Health, 2011 (accessed May 8, 2016). https://www.moh.gov.sg/content/dam/moh_web/HPP/Doctors/cpg_medical/current/2012/depression/Depression%20CPG_R14_FINAL.pdf.
20.
Kaiser Permanente: Adult Depression Clinical Practice Guideline. Oakland, Kaiser Permanente Medical Care Program, 2012 (accessed May 8, 2016). http://www.providers.kaiserpermanente.org/info_assets/cpp_cod/cod_depression_guideline_0712.pdf.
21.
DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (eds), for the Guideline Group Unipolar Depression: S3-Guideline/National Disease Management Guideline: Unipolar Depression, short version, ed 1, version 5. Berlin, ÄZQ, 2015 (accessed May 8, 2016). http://www.leitlinien.de/nvl/depression/.
22.
Duodecim: Depression. Helsinki, Duodecim Medical Publishing, 2014.
23.
Working Group of the Clinical Practice Guideline on the Management of Depression in Adults: Clinical Practice Guideline on the Management of Depression in Adults. Santiago de Compostela, Ministry of Health, Social Services and Equality/Galician Agency for Health Technology Assessment (Avalia-T), 2014 (accessed May 8, 2016). http://www.guiasalud.es/GPC/GPC_424_Adults_Dep_compl_en.pdf.
© 2016 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2016 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.